Latest Breaking News On - Medical technology company - Page 13 : comparemela.com

Dr. David Poppers to present on his initial experience with Lucid’s EsoCheck and EsoGuard NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed” or the “Company”), a highly differentiated, multi-product, commercial-stage medical technology company, and its major subsidiary Lucid Diagnostics Inc. (“Lucid”), announced today that David Poppers, M.D. Ph.D. will be presenting data on his team’s initial experience using Lucid’s EsoCheck® Esophageal Cell Collection Device and EsoGuard® Esophageal DNA Test at the upcoming Digestive Disease Week 2021 medical conference, which will be held virtually May 21-23, 2021. Dr. Poppers is Clinical Professor, Division of Gastroenterology and Hepatology at NYU Langone Medical Center in New York City, and an expert in advanced endoscopy and esophageal disease. His presentation, entitled EsoCheck/EsoGuard: a Novel, Simple, Outpatient Technology for the Ea

Lucid diagnostics incPavmed incMedical technology companyDigestive disease weekDavid poppersCollection deviceInitial experienceAmerican gastroenterological associationVascular access deviceதெளிவான பரிசோதனை இன்க்ஆவது இன்க்